hydroxycut

At the beginning of the month, our senior editor Brandi Koskie blogged about the Hydroxycut recall. Here’s a quick recap, and where it may (or should) lead with regards to future health legislation:

Is the Food & Drug Administration protecting consumers from dangerous and fraudulent claims by supplement makers, or are they simply reacting after the fact when it’s too late? That’s what the advocacy group called the Reality Coalition thinks. And there’s some merit to that claim. The group argues that the Dietary Supplement Health and Education Act (DSHEA), does little to protect consumers from unsafe supplements like Hydroxycut until it’s too late.

Following the death of a 19-year-old male and 23 reports of liver damage, the FDA has stepped in to warn consumers to discontinue use of the popular diet pill Hydroxycut. Hydroxycut manufacturer Iovate Health Sciences has agreed to recall 14 products from the market as “an abundance of caution.”

From the FDA press release — The FDA has received 23 reports of serious health problems ranging from jaundice and elevated liver enzymes, an indicator of potential liver injury, to liver damage requiring liver transplant. One death due to liver failure has been reported to the FDA. Other health problems reported include seizures; cardiovascular disorders; and rhabdomyolysis, a type of muscle damage that can lead to other serious health problems such as kidney failure.